aphidicolin has been researched along with Leukemia--T-Cell* in 2 studies
2 other study(ies) available for aphidicolin and Leukemia--T-Cell
Article | Year |
---|---|
Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle.
The effect of quercetin, a flavonoid found in many plants, on the proliferation of human leukemic T-cells was analyzed. Quercetin reversibly blocked the cell cycle at a point 3-6 h before the start of DNA synthesis. Expression of the growth-related genes histone H4, cyclin A and B, and p34cdc2 was suppressed in cells blocked with quercetin. Comparison of the quercetin arrest points with those of the cell cycle inhibitors aphidicolin and mimosine revealed a temporal order of arrest points in G1 of quercetin, mimosine, and aphidicolin. Mimosine and aphidicolin did not inhibit the expression of cyclin A or p34cdc2, whereas all three reagents inhibited expression of cyclin B. Low concentrations of the protein inhibitor cycloheximide inhibited release of the quercetin but not the mimosine or aphidicolin block. A [35S]methionine-labeled M(r) 60,000 protein disappeared in quercetin-treated cells and was rapidly synthesized after removal of quercetin, suggesting the possibility that the M(r) 60,000 protein induces DNA synthesis after the cell is released from a quercetin block. These results suggest the usefulness of quercetin in studies of the regulation of late G1 phase. Topics: Aphidicolin; CDC2 Protein Kinase; Cyclins; Cycloheximide; DNA, Neoplasm; Flow Cytometry; G1 Phase; Histones; Humans; Leukemia, T-Cell; Mimosine; Quercetin; RNA, Messenger; RNA, Neoplasm; S Phase; Time Factors; Tumor Cells, Cultured | 1992 |
DNA polymerase alpha defect in the N syndrome.
The N syndrome is characterized by mental retardation, malformations, chromosome breakage, and development of T-cell leukemia (Opitz et al.: Proceedings of the II International Congress IASSMD pp 115-119, 1971; Hess et al.: Clinical Genetics 6:237-246, 1974b, American Journal of Medical Genetics [supplement] 3:383-388, 1987). N syndrome fibroblasts were studied to see if the high chromosome breakage rate associated with this apparently X-linked syndrome could be related to a deficiency of DNA polymerase alpha, a product of a gene localized to the X chromosome. Bleomycin, which is known to break double-stranded DNA, produced increased chromosome breakage in normal control, Fanconi anemia, and N syndrome fibroblasts. When aphidicolin was used to inhibit repair mediated by DNA polymerase alpha, both normal control and Fanconi anemia fibroblasts showed significantly more chromosome breakage than was produced by bleomycin alone, but there was no increase in the amount of breakage seen in the N syndrome fibroblasts over that seen with bleomycin alone. This suggests that the N syndrome is due to a mutation affecting the region of the X chromosome on which the gene for DNA polymerase alpha is located, and that the high risk of T-cell leukemia observed in the hemizygote is due to this DNA repair defect. Topics: Abnormalities, Multiple; Aphidicolin; Bleomycin; Cells, Cultured; Child, Preschool; Chromosome Aberrations; Diterpenes; DNA Repair; DNA-Directed DNA Polymerase; Fanconi Anemia; Female; Humans; Intellectual Disability; Leukemia, T-Cell; Male; Syndrome; X Chromosome | 1990 |